<DOC>
	<DOCNO>NCT02005601</DOCNO>
	<brief_summary>We investigate impact duloxetine ( `` Cymbalta '' ) , serotonin norepinephrine reuptake inhibitor , pain total knee arthroplasty ( TKA ) . Specifically , investigator determine whether duloxetine , 60 mg daily 2 week , reduces pain score 2 week TKA .</brief_summary>
	<brief_title>Does Duloxetine Reduce Sub-Acute Pain After Knee Arthroplasty ?</brief_title>
	<detailed_description />
	<mesh_term>Acute Pain</mesh_term>
	<mesh_term>Duloxetine Hydrochloride</mesh_term>
	<criteria>Patients osteoarthritis schedule primary tricompartmental total knee arthroplasty participate surgeon Age 25 75 year Planned use regional anesthesia Ability follow study protocol English speaking ( primary outcome obtain via telephone call secondary outcome include questionnaire validate English ) Patients plan discharge home rehabilitation center agree participate Concurrent use duloxetine SNRIs , MAOIs , Tricyclic antidepressant , triptans ( sumatriptan , rizatriptan , naratriptan , zolmitriptan , eletriptan , almotriptan , frovatriptan ) , lithium , buspirone , St. John 's Wort Hepatic insufficiency Renal insufficiency Patients young 25 year old old 75 Patients intend receive general anesthesia Allergy intolerance one study medication Patients ASA IV Chronic gabapentin/pregabalin use ( regular use longer 3 month ) Chronic opioid use ( take opioids longer 3 month ) Patients major prior ipsilateral open knee surgery</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>